MENU

DermaTherapy Duvet Cover - Single size, Double size, King size, Super King size


  • This product has been tested on people with psoriasis and proven beneficial
  • Reduces friction with problematic skin
  • Helps control dampness, reduce irritation & promote better rest
  • Suitable for sufferers of eczema, pressure sores, acne etc.
£126.36 £159.95
Only 3 left ()
+
-
Currently sold out
  • Free shipping in all of UK
  • Next day delivery option
  • 30-day return policy

Description

DermaTherapy Bedding is specially designed to reduce friction, dampness and irritation. It is available in pure white in a range of the most popular sizes to suit most UK beds. The bedding is specially designed with a tab free zipper.

People with dry skin conditions often also suffer from poor sleep, due to irritation, itching, or soreness through the night. This is often made worse by bedding that is not really designed for their needs – the fabrics used in duvet covers, pillows, and sheets can aggravate the condition.

The DermaTherapy Duvet Cover is specifically designed to combat these problems and promote better rest for people with dry skin conditions like eczema, as well as those with pressure sores or acne. The cover reduces friction with the skin and therefore minimises the potential for trauma or irritation. It also helps to control dampness by rapidly absorbing moisture and channelling it away from the skin so that it can evaporate away and not cause irritation. It is zipper-free to avoid any accidental contact with sensitive skin that might even break the skin.

The DermaTherapy Duvet Cover is pure white and dust-mite proof, with a pore density (gap between the fibres) of less than 8.5 microns. It also has durable antimicrobial and soil release properties, maintaining a clean and healthy sleeping surface and minimising the risks of skin infection and bad odour.

It provides a simple and effective solution for dry skin sufferers looking for better rest and is available in all the standard UK bed-sizes (single, double, king, super king). It is washable at high temperatures.

Most duvet covers are made from cotton or a polycotton blend and do little to control moisture or friction. They often have short, protruding fibres or “pills” that can lead to friction, dampness, and irritation.

Because of the uniquely shaped microfibers in the construction of the DermaTherapy Duvet Cover, the skin is able to glide smoothly over the surface of the fabric. Moisture is wicked away from the skin by ‘channels’ in the fabric and it provides a frictionless feel on the skin. No lint or ‘pilling’ is produced (this is often seen with polycotton sheets).

DermaTherapy is the first bed linen to be classified as a Class I Medical Device for the treatment of mild atopic dermatitis, by both the American Food & Drug Administration in the U.S. and the European Union.

Research & Evidence

For people with Psoriasis

HelloSkin’s experts were unable to find clinical data on the use of DermaTherapy Duvet Cover in people living with psoriasis. However, the benefits of using the DermaTherapy fabric has been shown in people with atopic eczema in a study from 2008 based on 37 people with mild to moderate atopic dermatitis. After 8 weeks of use there was a significant decrease in severity and itching. Furthermore the study showed ‘some improvement’ in a quality of life index, and in general, patients reported significant improvement in the amount of itching experienced, tendency to scratch, and overall skin appearance (1).

For people with Eczema

The benefits the DermaTherapy fabric has been clinically shown in people with atopic eczema in a study from 2008 based on 37 people with mild to moderate atopic dermatitis. After 8 weeks of use there was a significant decrease in both severity and itching. Furthermore, the study also showed ‘some improvement’ in a quality of life index, and in general, patients reported significant improvement in the amount of itching experienced, tendency to scratch, and overall skin appearance (1).


References

  1. Pediatr Dermatol. 2008 Jul-Aug;25(4):439-43
- was added to your cart.